Asif Mahmood has diverse leadership experience as a health services professional with significant accomplishments in all aspects of pharmacovigilance, clinical development, medical affairs, regulatory affairs, primary health care, project management and international health programs. He has vast experience of working in diverse therapeutic areas including rare diseases, novel preventive and therapeutic vaccines, monoclonal antibodies, cardiovascular, oncology, neurology, nosocomial diseases, generic and OTC medicines. He is currently working as Disease Area Cluster Lead for Biosimilars and Drug Delivery Devices at Pfizer. His past experience includes working as Associate Vice-president PV and Therapeutic Area Head (Rare Diseases) for Sanofi Genzyme, working as Senior Director and Director for Vaccines PV at Sanofi Pasteur, working as Medical Consultant for Apotex Inc., Canada. Prior to joining industry, he had worked as Joint Executive Director for Pakistan Institute of Medical Sciences (PIMS), Registrar of the Post-graduate Medical Institute PIMS and as Deputy Director General, Ministry of Health Pakistan

Biosimilars & Drug Delivery Devices, pharmacovigilance, clinical development, rare diseases, novel preventive & therapeutic vaccines, monoclonal antibodies, generic and OTC medicines

Pierre A Morgon is the CEO of MRGN Advisors and Regional Partner for Switzerland at Merieux Developpement. He is also Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines and of Vaccitech. He has over 30 years of experience in the global Life Science industry, especially with vaccines and immunotherapy, at the HELM of international operations, in C-level positions at global level and as CEO of start-ups. He is a Lecturer in several MBA programs in world-class business schools and in Life Science conferences, as well as to the MassChallenge biotechnology incubator in Switzerland. He holds a Doctorate of Pharmacy, Master of Business Law and an MBA. He is also an Alumnus of INSEAD and IMD.

Pharmaceutical, biological industry and in healthcare

Soumen Pattanayek is currently a Sr. Research Fellow, Research & Development at Teva Pharmaceuticals, Weston, FL, USA (Formerly Actavis Laboratories FL, Inc.). He is responsible for product development and scale up of oral sustained and controlled release formulations. Soumen Pattanayek is working with Teva Pharmaceuticals, Weston, FL, USA for 10 years. He has developed multiple products through different platform technologies. Soumen has expertise in various technologies like Osmotic (bi-layer push pull system & monolithic system), MUPS (multi-unit pellet system), Matrix system, delayed release, coating controlled drug delivery system, compressed coated, bi-layer, wurster coating etc. Soumen has proven track record for working on novel drug delivery system. Soumen also has experience working on NCE. Previously Soumen was Research Scientist at Corepharma LLC, and has also served as group leader, Sun Pharma Advanced Research Center (SPARC), India. Soumen has over 15 years of experience in development and commercialization in the pharmaceutical industries.

controlled drug delivery systems (CDDS),

Dr. Zareen Delawar Hussain is the most diversified and pioneer Health care professional, entrepreneur and philanthropist in Bangladesh with significant accomplishments in all arena where she stepped. Professionally she is Cardiothoracic anesthesiologist and her 30 years incessant learning, dedication and commitment made her distinctive, well connective and confident. From her passion about creating meaningful changes in healthcare management, especially within terminally ill patients she focused this less tapped arena and played a significant role in advocating palliative care concepts in Bangladesh together with the team of Centre of Palliative Care in building a compassionate society. She has many stories to tell about the mindset of patients who are in their final journey, their thought about death and dying. She regularly takes part in courtyard meetings in slums to advocate palliative care. Now she is the General Secretary of Palliative Care Society of Bangladesh. She is an iconic first-generation female start up entrepreneur who initiated Invicta Pharma Care Limited for bringing world hit high technology pharma products and medical devices in Bangladesh at affordable price. For her personal visionaries resourcefulness she introduced couple of world’s block blaster product in Bangladesh at nominal cost. Later she became a stake of mid size pharmaceutical Manufacturer through merger for introducing specialized health care products for Bangladesh and Global market. Dr. Zareen is the founder Chairperson and Managing Director of Novo Invicta Specialized Health Care Limited. Over the last decade, Dr. Zareen has become an influential voice in the country for establishing women empowerment through economic independence of root level women, gender violence and stop child marriage. Dr. Zareen is a committed Zontian and also the charter President of Zonta club of Greater Dhaka. Zonta International is an organisation which has 30,000 members in 63 countries and holds highest NGO position in United Nations. The mission of Zonta is to empower women and girl child through service and advocacy. She started a pilot project for rehabilitating leprosy treated women by giving them sewing training at SINGER SEWING ACADEMY and at the end of the training a certificate of completion and a sewing machine. This has changed the lives of many such women who were isolated and looked down upon. Currently she is the Vice Area Director of Zonta international of Area 2, District 25. She is the popular media personality who is anchoring various health related shows in most of the television channels. Dr. Zareen has a clear mindset and keen eyes to expand her pharma industry in the middle east through either acquisition, merger or technology transfer. Dr. Zareen completed her MBBS in 1989 from Chittagong Medical College. She completed her post-graduation in Anesthesiology from Dhaka University. She completed fellowship in Cardiothoracic Anesthesiology from Escorts Heart Institute and Research Center, New Delhi, India. She also completed her basic certification course in palliative medicine from BSMMU.

1. Palliative care Service 2. Pharmaceutical Industry and Business Management

Yavuz Selim Silay is the Co-Founder and CEO of MAIN(MaQasid Angel Investors Network).He previously managed the largest distributor of Siemens Healthcare in Turkey.Yavuz previously worked as the Vice President of Ipsen pharmaceutical and Director of Teva pharmaceutical in USA

Interaction with FDA. Development of generic and branded regulatory strategic plans for new product development, life cycle management of marketed products. Evaluation of potential products & in-licensing opportunities.